CLOV, GOEV, CVAC and GTT among midday movers
- BySeeking Alpha-
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
CureVac NV (5CV)
80.60
-6.80(-7.78%)
- Volume:1,152,122
- Bid/Ask:80.47/81.25
- Day's Range:75.11 - 85.20
5CV Overview
- Prev. Close
- 87.4
- Day's Range
- 75.11-85.2
- Revenue
- -
- Open
- 85.01
- 52 wk Range
- 31.5-125.48
- EPS
- -
- Volume
- 1,152,122
- Market Cap
- -
- Dividend (Yield)
- N/A(N/A)
- Average Vol. (3m)
- 536,844
- P/E Ratio
- -
- Beta
- -
- 1-Year Change
- -
- Shares Outstanding
- -
- Next Earnings Date
- Sep 01, 2021
What is your sentiment on CureVac NV?
or
Market is currently closed. Voting is open during market hours.
CureVac NV News
- CureVac Drops on Report of Delayed EMA Approval
- ByInvesting.com-
By Christiana SciaudoneInvesting.com -- CureVac NV (NASDAQ:CVAC) tumbled almost 13% after Reuters reported the European Medicines Agency is unlikely to make a decision on its...
- CureVac (CVAC) shares rise 5% on encouraging CV2CoV data against COVID-19 variants
- BySeeking Alpha-
CureVac (CVAC) and collaboration partnerGlaxoSmithKline (GSK) announce thefirst preclinical data from second-generation COVID-19 vaccine candidate, CV2CoV in a rat model.CV2CoV is...
CureVac NV Analysis
- Opening Bell: Global Market Rebound Stumbles Ahead Of Crucial U.S. Data
Traders await US economic data to justify strongest monthly stock advance in 3 decadesOil rebound slowsBitcoin close to all-time highKey EventsThe most powerful global, monthly...
- In The COVID Vaccine Race, This ETF May Be A Better Bet Than Moderna Or Pfizer
As the world eagerly awaits results for the U.S. Presidential election, there's yet another highly anticipated event: a breakthrough in the coronavirus vaccine.Positive news about...
- Tempted By Hot IPO Stocks But Fear Getting Burned? Check Out These ETFs
Amid the recent declines in broader markets, a blockbuster stock debut has been making headlines: cloud-based data-warehousing firm Snowflake (NYSE:SNOW).While the company priced...
Technical Summary
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Buy |
| Technical Indicators | Strong Sell | Strong Sell | Sell | Sell | Strong Buy |
| Summary | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Buy |
Trending Stocks
Trending Stocks
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 2,430.20 | 2,441.72 | 2,418.96 | -4.93 | -0.20% | 1.10M | NASDAQ | |||
| 300.45 | 302.17 | 299.26 | +1.85 | +0.62% | 710.38K | NYSE | |||
| 331.26 | 332.83 | 328.93 | -1.20 | -0.36% | 13.59M | NASDAQ | |||
| 314.11 | 314.75 | 311.23 | +0.07 | +0.02% | 291.73K | NYSE | |||
| 642.11 | 642.95 | 634.83 | +1.34 | +0.21% | 1.02M | NASDAQ | |||
| 24.98 | 25.26 | 24.89 | +0.04 | +0.16% | 3.56M | NYSE | |||
| 18.26 | 18.75 | 18.08 | -0.04 | -0.22% | 638.00K | NASDAQ | |||
| 14.18 | 14.33 | 13.57 | +0.29 | +2.09% | 56.13M | NYSE | |||
| 69.40 | 69.40 | 69.40 | +0.03 | +0.04% | 1.06K | OTC Markets | |||
| 49.40 | 49.60 | 42.01 | +6.59 | +15.39% | 218.01M | NYSE | |||
| 32.02 | 33.43 | 31.44 | -0.76 | -2.32% | 2.42M | NYSE | |||
| 5.43 | 5.50 | 5.39 | -0.01 | -0.18% | 20.37M | NYSE | |||
| 211.64 | 213.46 | 211.00 | -1.43 | -0.67% | 12.28M | NYSE | |||
| 516.44 | 520.97 | 504.00 | +7.79 | +1.53% | 500.37K | NASDAQ | |||
| 50.80 | 50.80 | 10.02 | 0.0000 | 0.00% | 0.00 | OTC Markets |
CureVac NV Company Profile
CureVac NV Company Profile
CureVac AG is a Germany-based biotechnology company. The Company is engaged in the therapeutic development of messenger Ribonucleic Acid (mRNA) and RNA-based vaccines. CureVac AG focuses on developing vaccines for infectious diseases and drugs to treat cancer and rare diseases. The Company's pipeline focuses on three areas: cancer immunotherapy, prophylactic vaccines, and protein-based therapies.
Read More
- 2021-06-11 15:59:54
any opinion here ?- 2021-06-11 17:46:10
Looks like a nice entry point and I am in. GL everyone - 2021-06-12 03:36:13what do you mean to entry in 99.5 and to sell at 132.55 $ how can happen this ? are you sure , can you clarify more better please ? what means GL everyone ? best regards., Ray.
- 2021-06-11 11:44:55
soon 90..- 2021-06-11 15:59:44do you think will go to $90 down ?
- 2021-06-11 08:17:53What happens in pre?
- 2021-06-12 03:57:01hello Mr. Khalil i hope you are fine in Azerbajdjan. what is your feeling about Curevac will drop more down ? what is your impact ? when to entry to buy or not to buy ? best regards, Ray .
- 2021-06-09 02:57:00You have a treasure in your legs the BYD Co. the biggest producer of Electrical Busses , invest in BYD through Vienna Austria Stock Exchange with ticker symbol BY6 and you will not regret . in 30days the price will be double. invest in BYD BY6
- 2021-06-08 15:20:17
https://finance.yahoo.com/news/eu-regulator-does-not-expect-121745415.html- 2021-06-08 21:22:22thanks
- 2021-06-08 13:57:48huge drop today, any news that cause this ?
- 2021-06-08 14:00:43
approval is 2 month postponed
- 2021-06-08 12:15:58what happened?
- 2021-06-08 12:45:51https://finance.yahoo.com/news/eu-regulator-does-not-expect-121745415.htmlThe European Medicines Agency (EMA) does not expect to make a decision on the approval of German biotech group CureVac's COVID-19 vaccine before August, an off...
- 2021-06-07 14:22:21
Approval...this week???- 2021-06-07 19:52:47I hope so.... 🤞
- 2021-05-28 08:30:09Greatings from Germany. I guess it is a matter of days until we see the next move. As soon as we get some news in, the stock will follow the valuations of Moderna and Biontech (in your country you say Pfizer for the vaccine, but in realty it is Biontech.Alsdo German. The valuation of Biontech is 2,3 times higher and Curevac has the same product as well a a very famous shareholder . At the End of the year we will see the same valutaion for both. My guess is arround 80-100 billion. BestShow previous replies (2)
- 2021-06-11 15:49:50Dear Hasan do you think the price of Curevac will recover or will continue to drop down more ? what is your impact please ? thanks so much Mr. Kosebalaban ? are you Turkish ? i am Greek.
- 2021-06-11 15:55:30Hope so. It is a solid company with a solid product (mRNA). Essentially same stuff as Biontech and Moderna. nice to meet you, dear neighbour.
- 2021-06-11 15:58:37Indonesia ? i found it . nice to meet you we can co operate to exchange opinions please ?
- 2021-05-25 04:54:47
New Highs on way- 2021-05-25 11:12:53
after this resistance the way look's clean
- 2021-05-19 03:46:56any news ? on 2nd of June.
- 2021-05-11 16:11:29will dump more the prices ? more dump?
- 2021-05-06 20:14:46"Changes to international intellectual property rules require unanimous agreement" (...) ""The activists said a waiver alone would not increase the world’s vaccine supply. It must be accompanied by a process known as “tech transfer,” in which patent holders supply technical know-how and personnel." (...) “Handing needy countries a recipe book without the ingredients, safeguards and sizable work force needed will not help people waiting for the vaccine,” Dr. Michelle McMurry-Heath." (NYTIMES) I don't see that happening TBH. Just hard to imagine the cake will be shared or maybe I'm too cynical for this level of humanitarianism. Looking for a dip. What do you think?
- 2021-05-06 09:05:49is there a price action towards to correction of 20% from 130.50 now?
- 2021-05-06 10:27:01Biden killed vaccines related stocks with his his nonsense patent talk
- 2021-05-06 20:21:08Elliot AldersonHe's 140 years old, not enough time to mandate anything. Yeah, I know, I couldn't resist
- 2021-05-04 05:15:37Pop pop
- 2021-04-14 13:25:58Are earnings tommorrow? There are different dates lying around. Cheers.
- 2021-04-14 13:55:14Hi, Giuseppe. It's a secret, and we are not allowed to reveal any info.
- 2021-04-14 16:25:07Schizophrenia plus trading must be fun
- 2021-04-14 11:36:40Buy buy 150 + coming
- 2021-04-13 18:59:01
Why Zolex Zoka?- 2021-04-14 10:06:57World no longer belive in AZN and JNJ ,and on the other side world needs more and more vaccines. CureVac already signed charging contract with Bayer,Sanofi, Novartis ...etc. They will produce most vaccines. I said too low price 150$ ,when they come out from phase III. it will be rocket ,see you then ;-)
- 2021-04-14 14:40:50Ok its true. I’m in, with 200 shares
- 2021-04-14 14:42:30ARCT is more or less the same?!
- 2021-04-13 13:50:28on June 1st 2021. price will hit 150 $ :-)
- 2021-04-13 10:57:58It will fly. Just buy
- 2021-04-11 01:16:19Best stock ever . If ya know how to trade
- 2021-04-09 19:35:16Worst stock ever
- 2021-04-05 23:33:40Buy buy buy
- 2021-03-23 12:05:06Target hit . Next 200
- 2021-03-16 14:20:20
TP150
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.